Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 22,896 shares at $15.19 ($348K) on 2025-05-02, disclosed to the SEC on 2025-05-05.
Scheduled sale ($348k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.19 | 11,448 | $174K | 50.0% |
| 2 | $15.19 | 11,448 | $174K | 50.0% |
| Total | $15.19 avg | 22,896 | $348K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |
| ARQT | SELL | 2024-12-23 | $228K | — | Filing → |